LTR PHARMA LIMITED

All News LTR Pharma Limited

Equities

LTP

AU0000305294

Market Closed - Australian S.E. Other stock markets 11:40:14 28/06/2024 am IST			5-day change	1st Jan Change
0.78 ^AUD	+1.96%		+17.29%	+126.09%

07/06	LTR Pharma's Nasal Spray Treatment for Erectile Dysfunction Obtains Positive Early Results in Trial; Shares Surge 33%	MT
06/06	LTR Pharma Requests for Voluntary Suspension Pending Clinical Study Results	MT

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

LTR Pharma's Nasal Spray Treatment for Erectile Dysfunction Obtains Positive Early Results in Trial; Shares Surge 33%	07/06	MT
LTR Pharma Requests for Voluntary Suspension Pending Clinical Study Results	06/06	MT
LTR Pharma Concludes Final Dose in SPONTAN Study	25/03	MT
LTR Pharma Doses First SPONTAN Patients	19/03	MT
LTR Pharma Launches Patient Recruitment for Erectile Dysfunction Drug Clinical Study	19/02	MT
LTR Pharma Receives Manufacturing Validation for SPONTAN Bioequivalence Study; Shares Down 3%	06/02	MT
LTR Pharma to Conduct Bioequivalence Clinical Trial for Spontan in Q1 2024	19/12	MT
LTR Pharma Limited Receives Approval from the Bellberry Human Research Ethics Committee for Bioequivalence Clinical Trial	18/12	CI
LTR Pharma to Start Trading on Australian Bourse Following AU$7 Million IPO	08/12	MT
LTR Pharma Limited has completed an IPO in the amount of AUD 7 million.	07/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Stock Market
Equities
LTP Stock
News LTR Pharma Limited

Our Free Content Help you Secure and Increase the Performance of Your Investments

Securing my Investments

fermer